Aaron S Rosenberg

Aaron S Rosenberg

University of California Davis - Davis / United States
Medical and Health Sciences / Hematology
AD Scientific Index ID: 1748582
person_outline Aaron S Rosenberg's MOST POPULAR ARTICLES
1-) Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem …SK Kumar, SJ Jacobus, AD Cohen, M Weiss, N Callander, AK Singh, ...The Lancet Oncology 21 (10), 1317-1330, 20201232020
2-) Targeting MCL-1 in hematologic malignancies: Rationale and progressAH Wei, AW Roberts, A Spencer, AS Rosenberg, D Siegel, RB Walter, ...Blood reviews 44, 100672, 2020952020
3-) Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortalityA Brunson, A Lei, AS Rosenberg, RH White, T Keegan, T WunBritish journal of haematology 178 (2), 319-326, 20171302017
4-) Second primary malignant neoplasms and survival in adolescent and young adult cancer survivorsTHM Keegan, A Bleyer, AS Rosenberg, Q Li, M GoldfarbJAMA oncology 3 (11), 1554-1557, 20171292017
5-) Second primary malignancies in multiple myeloma: A reviewC Poh, T Keegan, AS RosenbergBlood reviews 46, 100757, 2021582021